Thomas Breuer - Articles and news items

GlaxoSmithKline logo

GSK receives positive CHMP opinion for Cervarix™ two-dose schedule

Industry news / 28 November 2013 / GlaxoSmithKline

GSK announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use is recommending marketing authorisation for a two-dose schedule in 9-14 year old girls for its cervical cancer vaccine, Cervarix™…

GlaxoSmithKline logo

GlaxoSmithKline receives European authorisation for Nimenrix™

Industry news, News / 27 April 2012 / GlaxoSmithKline

The European Commission has granted marketing authorisation for Nimenrix…

GlaxoSmithKline logo

GSK receives positive opinion in Europe from the CHMP for Nimenrix®

Industry news, News / 17 February 2012 / GlaxoSmithKline

The EMA’s CHMP has issued a positive opinion recommending marketing authorisation for Nimenrix® (MenACWY-TT)…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...